Unlocking the Next Chapter of the Kidney Care
EMPA-KIDNEY: Stepping into the Next Level in Chronic kidney disease management
Speakers
×
Dr. Gary Deed
Healthcare Plus Medical Center, Queensland, Australia
- General practitioner Coorparoo, Brisbane Australia
- Adjunct Senior Research Fellow Monash University
- National Chair Diabetes Specific Interest Group - RACGP 2011 – Present
- Member of the ADS/ANZOS Committee for Australian Diabetes Management Algorithm 2019 – Present
- Member of the ADS Clinical Guidelines/Standards Advisory Committee (CAC) Member of the RACGP Expert Committee - Quality Care 2018 – Present
- Editor of the RACGP/Diabetes Australia - General practice management of type 2 diabetes 2014 – Present
- Member of Implementation Reference Group - Australian National Diabetes Strategy 2016-2020
- Member Editorial Board - Endocrinology Today and Diabetes Therapies (International)
×
Dr. Brendon Neuen
George Institute for Global Health Australia
- Staff Specialist Nephrologist and Director of the Kidney Trials Unit at Royal North Shore Hospital
- Senior Research Fellow at The George Institute for Global Health, Australia
- Medical Degree at James Cook University with 1st Class Honours and an Academic Medal
- Masters in Global Health and Epidemiology from the University of Oxford under Clarendon Scholarship
- PhD, University of New South Wales with the Faculty Award for outstanding contribution to research
- Fellow of the Royal Australasian College of Physicians and a Fellow of the American Society of Nephrology
- Founding Secretariat of the SGLT2 Meta-Analysis Cardio-Renal Trialists' Consortium (SMART-C)
- He has published over 70 peer-reviewed articles in general medical and specialty journals (e.g. The Lancet, BMJ and Annals of Internal Medicine, Lancet Diabetes and Endocrinology, Circulation, and the Journal of the American Society of Nephrology)
- Serving on boards or committees of the Australasian Kidney Trials Network, Australian and New Zealand Society of Nephrology, and the International Society of Nephrology
- Editorial Fellow of the Journal of the American Society of Nephrology from 2019-2020
Join Webinar
Webinar ID: 966 5962 7546
29th February 2024, Thursday
7:00 – 8:30 PM (GMT +8)
Agenda
| Time (SGT) | Topic | Speaker |
|---|---|---|
| 7:00 PM | Opening Remarks | BI |
| 7:05 PM | Faculty Introductions and Scientific Agenda | Dr. Gary Deed |
| 7:10 PM | Check point #1: Evidence and Practice Interactive Session (Slido) | Dr. Gary Deed |
| 7:20 PM | Seizing Opportunities to Improve CKD Management | Dr. Brendon Neuen |
| 7:30 PM | Case Discussion and Clinical Practice Session Patient with HPN and CKD | Dr. Gary Deed and Dr. Brendon Neuen |
| 7:45 PM | Check point #2: Evidence and Practice Interactive Session (Slido) | Dr. Gary Deed |
| 7:50 PM | EMPA KIDNEY: Breaking New Grounds in CKD Care | Dr. Brendon Neuen |
| 8:10 PM | Open Forum and Q and A | Both |
| 8:30 PM | 5 Key Take Ways and Closing | Chairman |
For healthcare professionals only. This webinar is for educational purposes only with the intent to communicate the EMPA-KIDNEY trial results. Empagliflozin is not indicated for the treatment of patients with chronic kidney disease in the Korea. Please refer to the local approved product information for the current indication. Date: December 2023.